About Frederic Moll
Frederic Moll is a director at PROCEPT BioRobotics.
Form D filings name Frederic Moll as a director at MIVI Neuroscience and Accuryn Medical.
Frederic Moll reports to the SEC as a director, officer or major shareholder of 9 public companies, including SS Innovations International (SSII), Shockwave Medical (SWAV) and Intersect ENT (XENT).
Frederic Moll first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Frederic Moll in the role, so the role may have started earlier or lasted longer.
PC
PROCEPT BioRobotics Corp
Director
2021 – 2026 · Public company (PRCT)
SI
SS Innovations International, Inc.
Director and 10% owner
2024 – 2026 · Public company (SSII)
SI
Shockwave Medical, Inc.
Director
2019 – 2024 · Public company (SWAV)
II
Intersect ENT, Inc.
Director
2014 – 2021 · Public company (XENT)
LC
Lux Health Tech Acquisition Corp.
Director
2020 · Public company (LUXA)
VI
Venus Concept Inc.
Director
2017 – 2019 · Public company (VERO)
Potrero Medical, Inc.
Director
2019 · Hayward, CA
Medical monitoring systems help clinicians track critically ill patients' kidney function.
BI
Biolase, Inc.
Director
2013 – 2017 · Public company (BIOL)
MC
MAKO Surgical Corp.
Director
2008 – 2013 · Public company (MAKO)
HI
Hansen Medical Inc.
Executive Chairman
2006 – 2012 · Public company (HNSN)
Key Colleagues at Startups
The people Frederic Moll works with at each company, as listed on that company's latest Form D.
MIVI Neuroscience, Inc. · Form D, Dec 30, 2020
RC
Robert Colloton
CEO and director
SC
Sean Cheng
Director
CY
Craig Yeshton
Director
RS
Robert Stern
Director
TW
Taylor Whitman
Director
Potrero Medical, Inc. · Form D/A, Oct 29, 2019
JW
Jay Watkins
Director
AC
Alan Chesler
Director
CM
Carter Meyer
Director
JU
Joe Urban
President and CEO, director
DB
Daniel Burnett
Director